Graft-versus-host disease screening: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
Tarek Nafee (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There is no role for screening for GvHD. | There is no role for screening for GvHD. | ||
==Screening== | |||
There is no role for screening for GvHD. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 11: | Line 12: | ||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} | ||
Revision as of 14:29, 3 July 2017
|
Graft-versus-host disease |
|
Differentiating Graft-versus-host disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Graft-versus-host disease screening On the Web |
|
American Roentgen Ray Society Images of Graft-versus-host disease screening |
|
Risk calculators and risk factors for Graft-versus-host disease screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]
Overview
There is no role for screening for GvHD.
Screening
There is no role for screening for GvHD.